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Abstract
Objective—We developed a measure of allostatic load from electronic medical records (EMRs), 
which we named “Index of Cardiometabolic Health” (ICMH).
Methods—Data were collected from participants’ EMRs and a written survey in 2005. We 
computed allostatic load scores using the ICMH score and 2 previously described approaches.
Results—We included 1,865 employed adults who were 25–59 years old. Although the 
magnitude of the association was small, all methods of were predictive of SF-12 Physical 
component subscales (all p<0.001).
Conclusion—We found that the ICMH had similar relationships with health-related quality of 
life as previously reported in the literature.
Introduction
Allostatic load has been conceived as an early warning system that is comprised of 
biomarkers that could indicate early cumulative physiologic dysregulation across many 
cardiometabolic physiologic systems (Seeman et al., 2001), which may lead to the 
development of these chronic health conditions. Unlike the Framingham Risk Score (FRS), 
allostatic load is meant to be indicative of underlying wear and tear and not predictive on an 
individual basis of future cardiac events (D'Agostino et al., 2008). However, allostatic load is 
predictive of worse health outcomes including mortality (Wu et al., 2010, Seeman et al., 
2004b, Seeman et al., 2001, Borrell et al., 2010), future cardiac events (Seeman et al., 1997, 
Mottillo et al., 2010), functional decline (Seeman et al., 2001, Karlamangla et al., 2002), and 
frailty (Gruenewald et al., 2009, Szanton et al., 2009). Likewise, greater allostatic load is 
also associated with worse patient reported health outcomes such as poorer self-rated health 
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and poorer performance on activities of daily living (Seplaki et al., 2004, Seplaki et al., 
2006). However, the effect sizes of these relationships are small with studies finding that an 
increase in one point in allostatic load (on a 11 point scale) was associated with a 0.04 to 
0.06 increase in units of self-rated health (measured with Excellent being 5 points and poor 
being 1 point) (Todorova et al., 2013, Read and Grundy, 2014). The association between 
allostatic load and both self-rated and functional status has also been found to be modest 
with allostatic load only explaining small 0.2–5% in the variance of these outcomes over and 
age and sex (Seplaki et al., 2006). Despite the small magnitude of the associations between 
allostatic load and self-rated health / functional status, these associations have consistently 
been reported in the literature.
Allostatic load may also represent an important mechanism of action for the effects of stress 
on health. Several studies have found that individuals with higher cumulative stress levels, 
such as African Americans and individuals with lower socioeconomic status, have higher 
allostatic load (Gruenewald et al., 2012, Deuster et al., 2011, Geronimus et al., 2006, Chyu 
and Upchurch, 2011, Bird et al., 2010, Gustafsson et al., 2011). Chronic stress is also 
associated with both increased likelihood of having higher allostatic load (Gustafsson et al., 
2012).
Although allostatic load and metabolic syndrome have been found to be predictive of other 
health outcomes, the current process of ascertaining allostatic load in population health 
research studies includes many biomarkers that are difficult to obtain on a population level 
such as epinephrine, norepinephrine, cortisol, dehydroepiandrosterone sulfate, insulin-like 
growth factor-1 and interleukin-6 (Seplaki et al., 2006). This is why prospective studies, 
with extensive biomarker collection on small samples, have historically been the basis for 
allostatic load measurement. The complexity involved in measuring allostatic load and the 
difficulty associated with obtaining extensive biomarkers has constrained research using 
allostatic load to select populations including cohorts of seniors (for example, the 
MacArthur Study of Successful Aging), the National Health and Nutrition Examination 
Survey and specific clinical populations (Beckie, 2012).
With implementation of electronic medical records (EMRs), collection of component items 
of allostatic load has become increasingly common in large patient populations. However, 
uncertainty remains about whether the concept of allostasis can be operationalized using the 
unplanned but extensive collection of biomarkers that occurs routine medical care delivery. 
In this study, we outline and evaluate a method for evaluating physiologic dysregulation 
using a z-score based methodology, the Index of Cardiometabolic Health (ICMH). The 
ICMH follows the conceptual model of allostasis and its operationalization using z-scores 
that has been put forth in previous other studies (Seplaki et al., 2005). We examine ICMH 
based on biomarkers collected in routine practice among three condition cohorts (patients 
with diabetes, multiple cardiovascular risks, and healthy individuals). We aim introduce a 
new measure of allostatic load that is easily obtained from data routinely collected from 
healthcare. Thus, the primary objective was to describe the approach to calculating and 
creating the ICMH. The secondary objective is to compare the performance of the ICMH to 
other allostatic load measures. Unlike the ICMH, these other allostatic load measures 
(further description included in Table 1) are based on cut points and include some hard to 
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measure biomarkers, measures that are very rarely collected in routine primary care. The 
ICMH also includes 8 of the biomarker measures commonly used in other allostatic load 
measures. The third objective is to demonstrate the construct validity of the ICMH by 
determining its’ association with health-related quality of life. Specifically, we will 
determine the construct validity of ICMH and other measures of allostatic load using EMR 
data by determining whether they are associated with worse health-related quality of life. 
Several articles have found that worse allostatic load is associated with worse aspects of 




Kaiser Permanente Georgia (KPGA) is a federally-qualified HMO (health maintenance 
organization) that at the time of this study provided comprehensive medical services to 
approximately 275,000 residents in the Atlanta metropolitan area. The study protocol 
(including survey and survey administration) was reviewed, approved and monitored by the 
KPGA Institutional Review Board.
Study Sample
Participants were given the survey in written form, with an option to complete the survey on 
a website, during the period from October to December 2005. The survey was administered 
by a professional survey service, which handled data collection. A $2 incentive was given in 
the initial mailing. If participants did not respond after 5–6 weeks, reminder postcards, an 
additional full survey packet, and a friendly phone call reminder to non-respondents 
followed in this order.
Inclusion in the KPGA sample required: 1) enrollment with KPGA since January 2004; 2) 
subscriber within the enrolled family; 3) employment by one of the 100 largest private or 
public employer groups offering KPGA as an insurance option, and 4) participant age 
between 25 and 59 years, inclusive, as of August 31, 2005. A stratified randomized design 
was used to collect relatively well-balanced samples of respondents by condition cohort and 
by primary care practice. Three condition cohorts were identified for sampling: adults with 
diabetes, adults with elevated lipids and at least one other cardiovascular disease risk factor 
(e.g. hypertension or current tobacco smoking) but no history of advanced coronary artery 
disease (herein after “adults with cardiovascular risks”), and "low risk" adults (i.e. adults 
without any identifiable major physical or mental morbidities). Identification of these 
cohorts was accomplished by application of computer algorithms that ascertained evidence 
of disease from diagnoses on outpatient and inpatient care (e.g. ICD-9 or International 
Classification of Disease version 9 codes for diabetes), pharmacy dispensing’s (e.g. insulin 
and oral hypoglycemic), and laboratory results (e.g. HbA1c>7.0%). These sampling criteria 
identified 5,309 potential participants. Of these, 2,224 (43%) completed the 2005 survey. 
Only individuals who self-categorized themselves as African American or white were 
included in this analysis (2,029 of 2,224).
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Participants reported physical and emotional functioning. These were measured in the 
survey using the Physical Component Summary (PCS-12) and Mental Component Summary 
(MCS-12) scales of the SF-12 (Ware et al., 1996). The scales have been standardized to have 
a mean of 50 and a standard deviation of 10 and are bounded by 0 and 100, with low scores 
representing poor physical or emotional functioning and high scores representing excellent 
physical or emotional functioning. PCS-12 and MCS-12 from the SF-12 have been shown to 
have good validity and high test-retest reliability (Ware et al., 1996). Estimates of test-retest 
reliability for PCS-12 and MCS-12 are 0.89 and 0.76 respectively.
Ascertainment of ICMH
Component measures for computing allostatic load were extracted from KPGA’s EMR data 
system. There were two primary data sources within the system: primary care visits and 
laboratory results. Primary care visits were defined as a face-to-face visit with a physician, 
physician’s assistant or a nurse practitioner in adult medicine or obstetrics/gynecology 
during routine office hours (i.e. after hours visits for urgent care were excluded). Height and 
weight, systolic blood pressure (SBP), and diastolic blood pressure (DBP) assessed on 
primary care visits. Height and weight were used to compute body mass index (BMI) 
calculated by weight in kilograms divided by a square of the height in meters, SBP and DBP 
were used individually and also to compute mean arterial pressure (MAP) by using the 
formula: the sum of one third of the systolic blood pressure and two thirds of the diastolic 
blood pressure.
Laboratory results (e.g. hemoglobin A1c, total cholesterol, low density lipoprotein, high 
density lipoprotein, serum creatinine, serum albumin, C-reactive protein) associated with 
outpatient (but not inpatient) services were obtained. Estimated glomerular filtration rate 
(eGFR) was calculated from serum creatinine, gender, and age at time of the test, using the 
Cockroft-Gault formula. Most laboratory tests are ordered by primary care physicians; but 
because there was no screen by ordering physician specialty, the laboratory test results also 
included tests ordered by medical subspecialists.
For each respondent, component measures were summarized into a measure for 2005. If a 
respondent had more than one result for a component measure in 2005 (e.g. 2 HbA1c 
results), then the median of the results for that respondent was retained for the component 
measure. Since most respondents had none, one, or two results on a component measure in 
2005, the mean and median were equivalent for most respondents.
We computed allostatic load scores based on three approaches previously described in the 
literature, including the approach by Geronimus et. al.(Geronimus et al., 2006), Crimmins et. 
al. (Crimmins et al., 2003), as well as the ICMH, which is a z-score based approach. For the 
3 previously published allostatic load approaches, a higher score was associated with worse 
physiologic status. For the ICMH measure – in which we wanted to emphasize good 
physiologic health – a higher score was associated with better physiologic status. Due to the 
nature of the EMR data, not all participants had values for all component measures. The 
Seeman et. al. method includes 10 components and participants were given one point for 
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each measure that exceeded an adverse (high or low) threshold, with cut points established 
using NHANES data (Beckie, 2012). The Crimmins allostatic load measurement method 
refers to a method of computing allostatic load based on 12 bio-markers and both clinical 
and NHANES cut points first described by Crimmins et. al. (Crimmins et al., 2003). The 
Crimmins measures includes all the components of the Seeman et. al. method, but also 
includes fasting blood glucose and high density lipoprotein (Crimmins et al., 2003). 
Moreover, the Crimmins-based method uses cut points based on both NHANES and clinical 
criteria for some component measures such as blood pressure (Table 1). The index of 
cardiometabolic health (ICMH), a z-score based approach, standardizes each component 
measure based on the sample mean on a scale of 0–100, and with a mean of 50 and a 
standard deviation of 12.5. The mean of the component measures is the overall ICMH score. 
Thus, higher values on ICMH represent lower allostatic load, or better physiologic health. 
The ICMH includes 8 biomarkers that are commonly used in the Crimmins et. al. and the 
Seeman’s et.al. approach.
Covariates
Respondent-level covariates included: condition cohort, age group, gender, race/ethnicity, 
and educational attainment. Condition cohort (diabetes, cardiovascular risks, low risk), age 
in years, and gender were assessed from KPGA computerized data. Race/ethnicity (African 
American, white, other/unknown) and educational attainment (less than a high-school 
education, high school education, some college, and college graduate, post-graduate) were 
also assessed using survey data.
Statistical Analysis
We conducted descriptive statistics analysis in order to determine and compare the 
characteristics of the three cohorts (diabetes, cardiovascular risks, and low risk). We also 
conducted descriptive statistics to examine all three allostatic load measures and their 
components. For each method of calculating allostatic load, we examined the mean number 
of component measures per person. Bivariate relationships between demographic 
characteristics and allostatic load scores of all three measures were conducted using one-
way ANOVA tests. We then used ordinary least squares linear regression to determine the 
multivariate relationships between baseline demographic characteristics and all three 
measures of allostatic load.
We determined both the bivariate and multivariate relationship between both PCS-12 and 
MCS-12 and all 3 measures of allostatic load, using one-way ANOVA tests and linear 
regression. We regressed all three measures of allostatic load and both PCS-12 and MCS-12 
respectively as outcomes. Thus, we generated 6 separate linear regressions adjusting for all 
covariates. We then conducted analyses stratified based on sex and then race in order to 
determine whether the relationship between all measures of allostatic load and PCS-12 and 
MCS-12 differed by sex or race. Due to the inherent differences in the allostatic load and 
ICMH measurement specifications, we reported only standardized beta coefficients. To 
create standardized beta coefficients, we divided each allostatic load score or ICMH by the 
standard deviation of the allostatic load score, respectively, that was calculated from the 
study sample. We used the same standard deviation regardless of whether the analysis was 
Nobel et al. Page 5













stratified or not. Thus, each beta-coefficient was only x-standardized and not fully 
standardized, so that each co-efficient corresponds to the average effect of a one standard 
deviation unit change in allostatic load on MCS-12 or PCS-12 after adjusting for baseline 
demographic characteristics. For each regression model, we calculated the semi-partial 
correlation (or the incremental increase in R-squared), after adding each method of allostatic 
measurement to a linear regression model adjusted for age, sex, race and education. We 
examined relevant interactions including those for all of the covariates mentioned previously 
with each measurement of allostatic load. All statistical tests were performed using Stata 11 
(StataCorp., 2009).
Results
Excluding individuals with missing information for race, education, PCS-12, MCS-12, and 
any allostatic load or ICMH component measure, there were a total of 1,865 of the original 
sample of 2,029 individuals (91.9%) White or African American participants with complete 
data for analysis: 546 with diabetes, 666 with cardiovascular risks, and 653 “low risk 
adults”. Our sample was predominantly female (60.7%) with approximately half of the 
participants being white (51.3%) and middle aged (average age 48.4 (SD 6.8)). Most 
participants were well educated, with 82.6% of participants having had at least some college. 
Table 2 shows participant characteristics and their relationship to the condition cohort. 
Individuals in the “low risk” category tended to be more likely to be in the highest quartile 
of PCS-12, while those in the other condition cohorts had lower scores (p<0.01). However, 
MCS-12 did not show any apparent relationship with condition cohort.
Table 3 demonstrates that regardless of the method of allostatic load measurement, 
individuals who were older tended to have more allostatic load (Crimmins p<0.01, Seeman 
p<0.01, ICMH p<0.01). Regardless, of the method of measuring allostatic load, there were 
significant differences in allostatic load score between African Americans and whites 
(Crimmins p=0.02, Seeman p<0.01, ICMH p<0.01), but there were no differences found 
between males and females (Crimmins p=0.48, Seeman p=0.38, ICMH p=0.64). Participants 
with lower scores of physical component score of the SF-12 (PCS-12) tended to have 
significantly higher allostatic load, regardless of the method of measurement of allostatic 
load (Crimmins p<0.01, Seeman p<0.01, ICMH p<0.01). However, there were no 
differences in allostatic load between participants with different mental component scores of 
the SF-12 (MCS-12) (Crimmins p=0.13, Seeman p=0.10, ICMH p=0.64).
Table 4 demonstrates the mean number of components included in each separate measure of 
allostatic load. The mean number of component measures included in each of the different 
methods of computing allostatic load scores varied from an average of 4.43 (SD 1.68) for the 
Seeman measure to an average of 5.48 (SD 2.96) for ICMH. Everyone in the sample had a 
measure for body mass index and the majority of participants had values for cholesterol 
(74.0%), high density lipoproteins (73.1%) and low density lipoproteins (72.9%). 
Approximately half of participants had information regarding triglycerides (56.9%) and 
mean arterial pressure (54.1%). Biomarkers that were less likely to have values included 
albumin (24.2%), hemoglobin A1c (25.7%), Urine albumin/creatinine ratio (16.3%), and 
estimated glomerular filtration ratio (36.3%). There were no significant differences in the 
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number of component measures per participant by gender for all of the methods of 
determining allostatic load (Crimmins p=0.57, Seeman p=0.42, ICMH p=0.84). However, 
African Americans tended to have a higher number of mean component measures per 
participant when compared to whites for all of the methods of determining allostatic load 
(Crimmins p<0.01, Seeman p<0.01, ICMH p<0.01). Older individuals also tended to have a 
higher mean number of component measures per participant when compared to younger 
individuals (Crimmins p<0.01, Seeman p<0.01, ICMH p<0.01).
Table 5 presents socio-demographic factors associated with both allostatic load and ICMH at 
baseline. African Americans and older individuals had significantly worse allostatic load and 
cardiometabolic health, as measured by the ICMH (Table 5). Gender and education did not 
have statistically significant relationships with either allostatic load or the ICMH.
Standardized beta coefficients from multiple linear regressions, regressing each different 
method of allostatic load onto the outcome of PCS-12 and MCS-12 are shown in Table 6. 
For example, the standardized beta coefficients for the regression of Crimmins onto PCS-12 
shows that for each standard deviation increase in the Crimmins score, the PCS-12 score 
decreases on average 1.51 (95% CI −1.89, −1.13) points after adjusting for age, sex, race 
and education. All of the methods of allostatic load measurement showed that increased 
allostatic load was associated with statistically significant lower PCS-12 scores. ICMH was 
scored in terms of physiologic health (or less allostatic load) and thus had an opposite 
direction. This remained true regardless of whether the data were stratified by sex or race. 
However, there was no consistent pattern between methods of allostatic load measurement 
and MCS-12 scores either overall or stratified by sex or race.
For all of the methods of allostatic load measurement, there was a statistically significant R-
squared for the outcome of PCS-12. The semi-partial correlations (or incremental increase in 
R-squared) represents the percentage of the additional variance of PCS-12 or MCS-12 that is 
explained by each method of allostatic load measurement, after adjustment for age, sex, race 
and education. However, the amount of additional variation explained by these methods of 
allostatic load measurement was relatively small, whereby all of the methods explained less 
than 4% of the additional variance of R-squared after adjustment for other covariates. This 
remained true for all strata. For MCS-12 however, there was no clear pattern of different 
methods of allostatic load measurement having statistically significant adjusted R-squares.
Discussion
The primary objective of this study was to present a new measure of cardiometabolic health, 
the ICMH, and to examine the validity of the ICMH. We were able to determine the validity 
of the ICMH in several ways. First, we found that individuals in previous studies who had 
greater allostatic load using other conceptualizations of allostatic load also had worse 
ICMH. Second, we were able to reproduce the typical associations between socio-
demographic data and allostatic load. Older individuals, African Americans and those with 
lower educational attainment had higher allostatic load across all measures. Third, we found 
that the ICMH and 2 established measures for assessing allostatic load using routinely 
collected vital status and laboratory measures were predictive of physical functioning in the 
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same way that prospective collection of vital status and laboratory measures stratifies 
nationally representative samples of adults. Although the magnitude of the association was 
small, all methods of allostatic load measurement were predictive of the physical component 
score of the SF-12. In contrast, none of the measures of the methods of calculating allostatic 
load were associated with the mental components of the SF-12.
Our findings using the ICMH parallel the findings of other studies who have found that 
African Americans and those who are older or have lower socio-economic status have worse 
allostatic load (Seeman et al., 2004a, HU et al., 2007). This provides evidence that the 
ICMH is an effective tool to measure allostatic load using electronic health records amongst 
the general working age population. However, our study, in contrast to other studies in the 
literature did not find any gender differences in allostatic load score (Yang and Kozloski, 
2011). This may in part be due to a limitation in EMRs as a source for our measure of 
allostatic load as women tended to have higher inflammatory biomarkers when compared to 
their male counterparts (Beckie, 2012). Because our inflammatory markers such as CRP are 
less likely to be routinely ordered in primary care it is likely that the index of physiologic 
health may underestimate allostatic load for women.
Several studies have found that worse allostatic load using prospectively collected data on 
samples of large populations is associated with worse self-rated health and worse 
performance on activities of daily living (Seplaki et al., 2004, Seplaki et al., 2006). Like, 
previous studies, our study found that allostatic load measured using biomarkers collected 
during routine practice was associated with worse physical functioning. This remained true, 
regardless of what gender, racial, or clinical condition (diabetes, cardiovascular risks, low 
risk) subgroups we examined. Our study used electronic medical records that collect data 
from patient visits as compared with prospective data collection; and, we found concordant 
associations of physiologic dysregulation with self-reported physical health that were similar 
to the concordance found in studies of allostatic load using prospectively collected 
biomarker samples. However, although we found a statistically significant association 
between all measures of allostatic load (including the ICMH) and PCS-12, the magnitude of 
the association was small where a two standard deviation change in ICMH score was 
associated with a 3 points change in PCS-12 which may be equivalent to a minimally 
important difference in PCS (Revicki et al., 2006). The magnitude of relationship between 
all measures of allostatic load or ICMH explored in this study and worse SF-12 scores may 
be explained by the short time frame of this study. This is largely expected as allostatic load 
and the ICMH is meant to measure physiologic dysregulation and while stress and mental 
health issues may result in higher allostatic load or a poorer ICMH score, it is unlikely that 
higher allostatic load or a poorer ICMH score would be the cause in a 1–2 year time frame.
One of the more unexpected findings of our study was that allostatic load or ICMH, 
regardless of the scoring algorithm used, only accounted for a very small portion of the 
variance in physical functioning scores. This may in partbe due to the fact that the wear and 
tear associated with allostatic load takes time to develop and result in measurable health 
impairments. This would be especially true amongst our healthy working study population. 
This is especially supported by the strong association of worse allostatic load and ICMH 
with higher age, thereby implying that over the life course the wear and tear of allostatic 
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load as measured by ICMH had time to accumulate. Moreover, although our estimates of the 
percentage of variance explained by allostatic load were low, they are not unreasonable 
given the current literature (Seeman et al., 1997, Beckie, 2012).
Due to the plethora of different techniques used to measure allostatic load, several studies 
have examined whether the method of allostatic load measurement changes any findings. In 
particular, Seplaki et. al. found that allostatic load measures based on a set of cut-points, 
such as the methods by Crimmins et. al. (Crimmins et al., 2003) and Seeman et. al. (Beckie, 
2012), did not perform as well as those based on z-scores such as the ICMH (Seplaki et al., 
2005). Our study found that the association between both more traditional cut point based 
methods and the z-score based ICMH with PCS-12 did not differ substantially between 
types of allostatic load measurement. This is in line with the conclusions of a recent 
systematic review by Beckie et. al which concluded that the association between allostatic 
load and health impairment did not vary according which individual biomarkers were 
included or whether the measure of allostatic load was based on a z-score based measure or 
cut points (Beckie, 2012).
Other indices of short- and long-term predictive effects of cardiometabolic risk have been 
proposed, most notably the Framingham Risk Score (FRS) (Wilson et al., 1998). The ICMH 
differs from the FRS in several ways. ICMH is not intended to predict any specific endpoint 
at the individual level, but rather represents a general measure of cardiometabolic risk to be 
used on the population level. FRS is calibrated specifically to predict the risk of coronary 
heart disease (CHD) – one of many endpoints that can occur as a consequence of a range of 
pre-existing cardiometabolic risks. Additionally, the ICMH can include the following 
measures which are not included in the Framingham risk score such as GFR, serum and 
urinary albumin levels etc. Moreover, ICMH is not based on age or gender or disease; and, 
in fact can explain some variation in health independent of age or gender or disease. FRS 
substantially relies on age and gender for prediction of cardiometabolic risk. In fact, among 
men the strongest association of CHD with the FRS risk factors is with age; and, among 
women, age is as strong as SBP or DBP in predicting CHD (Table 1) (D'Agostino et al., 
2008). ICMH does not rely on specific indicators of presence of a specific cardiometabolic 
disease – as does FRS (e.g. diabetes) – but rather relies on biomarkers indicative of gradients 
in physiologic status indicative of a disease or level of control of an existing disease (e.g. 
HbA1c levels). These biomarkers indicate level of glycemic control which is the most 
important factor explaining risk of subsequent micro- and macro-vascular disease (Stratton 
et al., 2000, 1993).
Our study is not the first to investigate the ability of using EMR data to measure indices of 
health. A previous study by Hivert et. al. found that metabolic syndrome could be measured 
using EMRs (Hivert et al., 2012). The creation of the ICMH builds on this previous work 
and is the first measure of allostatic load based on data contained in electronic health 
records. However, metabolic syndrome as defined by the International Diabetes Federation 
includes measures of central obesity, lipid abnormalities, high blood pressure, high glucose 
or fasting glucose (Alberti et al., 2006). Unlike the current definition of metabolic syndrome, 
the ICMH also includes measures of renal function such as eGFR and is a z-score based 
method and not based on cut points.
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Our development and evaluation of the ICMH has several important implications for 
extension of the concept of allostatic load to measurement of physiologic dysregulation in 
routine research practice. One of the major limitations of previous work on allostatic load is 
that it requires many biomarkers that may require multiple measurements at pre-specified 
times of day (e.g., morning salivary cortisol) (Beckie, 2012). In addition, other typical 
components of allostatic load measures, such as neuroendocrine markers (like cortisol and 
epinephrine etc.) and inflammatory markers (like interleukin-6 and tumor necrosis factor), 
are rarely assayed in routine clinical care. This is largely because physicians are much more 
likely to order tests for biomarkers that are related to cardiac and metabolic health (e.g., low 
density lipoprotein or hemoglobin A1c) which the ICMH emphasizes. The majority of 
current studies on allostatic load have been confined to specialized samples that either 
include only older individuals (for example MacArthur cohort of aging, Taiwanese and 
Swedish Aging studies), NHANES and measurement of allostatic load in specific clinical 
populations (Beckie, 2012). However, the ICMH broadens the ability to conduct allostatic 
load research by using data from EMRs and not including any neuroendocrine or 
inflammatory measures side from c-reactive protein. Therefore, the ICMH can be used in 
more settings and using fewer resources.
Some might argue that the emphasis of the ICMH on cardiac and metabolic component 
measures is a limitation of the concept of allostatic load. This may be especially important 
for women given that the inflammatory bio-markers may be more important markers of 
allostatic load amongst women (Beckie, 2012). Although the lack of inflammatory bio-
markers may be a problem, we found that on average 4–5 biomarkers in patients’ EMRs 
were applicable to measurement of allostatic load. One additional limitation may be 
measurement bias due to the fact that individuals without any symptoms may be less likely 
to obtain regular healthcare and get the required clinical evaluation that would reveal 
underlying allostatic load buildup. In order to attempt to counteract this measurement bias 
we sampled 3 cohorts based on prior history of medical condition (diabetes, cardiovascular 
risks, low risk). However, this means that our sample is not strictly a random sample.
Conclusion
In conclusion, we propose that the ICMH represents a new way to use EMR data in order to 
measure and track allostatic load in the general population. Being able to track ICMH over 
time through EMR data allows us to extend the breadth of allostatic load research by 
allowing investigators to research allostatic load using more available electronic health 
record data as opposed to expensive and difficult to obtain physiologic bio-markers. As we 
enter an era where the adoption and usability of electronic health record data increases we 
will be able to use this data to measure previously hard to measure concepts such as 
allostatic load on a wider variety of populations. Moreover as the research using electronic 
health record data on allostatic load increases, public health officials could track the 
allostatic load of large portions of the population once as electronic health record data 
continue to become more common and standardized across multiple health care systems.
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Table 1
Description of Methods for calculating allostatic load




Itemized Component Measures Creatinine Clearance Creatinine Clearance eGFR





-- Fasting blood glucose --




C-reactive protein C-reactive protein --
Homocysteine Homocysteine --
--- --- Urine albumin/creatinine ratio
Scoring Rules 1 point for each measure 
exceeding an adverse (high or 
low) threshold established 
using NHANES distributions
1 point for each measure (*) 
exceeding and adverse (high or 
low) threshold established using 
either clinical criteria (e.g. BP) or 
NHANES distributions
Each measure standardized to a 
mean of 0 and std. deviation of 1 in 
each year (**).
Standard deviations beyond ± 4 
recoded to ± 4.
Standardized [0, 1] values recoded to 
[50, 12.5]
Z-score Method 1: standardizes to 
the total sample average.
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Table 6
Association between Measure of Allostatic Load and Physical and Mental Component Subscales of the SF-12*
Measure of
Allostatic Load
Physical Component Subscale of SF-12 Mental Component Subscale of SF-12
Beta (95% CI) Beta (95% CI)
Crimmins −1.51 (−1.89, −1.13) −0.46 (−0.92, 0.01)
Seeman −1.34 (−1.71, −0.97) −0.52 (−0.97, −0.07)
ICMH 1.14 (0.80, 1.48) 0.29 (−0.11, 0.70)
*
Linear regressions were adjusted for age, sex, race and education. Each method of allostatic load was x-standardized so that it corresponds to the 
average effect of a one standard deviation unit change in allostatic load on MCS-12 or PCS-12.
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